mortality/aging
• 10% of mice die by week 24 compared with 50% of Faslpr/Faslpr Il27ratm1Mak/Il27ra+ mice
|
immune system
N |
• mice exhibit unaltered lymphocyte compartment compared with Faslpr/Faslpr Il27ratm1Mak/Il27ra+ mice
|
• compared to in Faslpr/Faslpr Il27ratm1Mak/Il27ra+ mice
|
• mice exhibit increased IgG1 depositions in the kidneys compared with Faslpr/Faslpr Il27ratm1Mak/Il27ra+ mice
• IgG1 serum levels are increased compared to in Faslpr/Faslpr Il27ratm1Mak/Il27ra+ mice
|
• mice exhibit reduced IgG2a renal deposits and serum levels compared to in Faslpr/Faslpr Il27ratm1Mak/Il27ra+ mice
|
• Th2-type immune response is favored compared to in Faslpr/Faslpr Il27ratm1Mak/Il27ra+ mice
|
• compared to in Faslpr/Faslpr Il27ratm1Mak/Il27ra+ mice
|
• compared to in Faslpr/Faslpr Il27ratm1Mak/Il27ra+ mice
|
• 10-fold in stimulated CD4+ T cells compared with similarly treated Faslpr/Faslpr Il27ratm1Mak/Il27ra+ cells
|
• mice exhibit improved survival, creatinine serum level, blood urea nitrogen serum level, and renal injury compared with Faslpr/Faslpr Il27ratm1Mak/Il27ra+ mice
|
• compared to in Faslpr/Faslpr Il27ratm1Mak/Il27ra+ mice
|
• mice develop membranous glomerulonephritis
|
renal/urinary system
• mice develop membranous glomerulonephritis
|
homeostasis/metabolism
• compared to in Faslpr/Faslpr Il27ratm1Mak/Il27ra+ mice
|
• compared to in Faslpr/Faslpr Il27ratm1Mak/Il27ra+ mice
|
• compared to in Faslpr/Faslpr Il27ratm1Mak/Il27ra+ mice
|
• compared to in Faslpr/Faslpr Il27ratm1Mak/Il27ra+ mice
|
hematopoietic system
• compared to in Faslpr/Faslpr Il27ratm1Mak/Il27ra+ mice
|
• mice exhibit increased IgG1 depositions in the kidneys compared with Faslpr/Faslpr Il27ratm1Mak/Il27ra+ mice
• IgG1 serum levels are increased compared to in Faslpr/Faslpr Il27ratm1Mak/Il27ra+ mice
|
• mice exhibit reduced IgG2a renal deposits and serum levels compared to in Faslpr/Faslpr Il27ratm1Mak/Il27ra+ mice
|
• Th2-type immune response is favored compared to in Faslpr/Faslpr Il27ratm1Mak/Il27ra+ mice
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
membranous glomerulonephritis | DOID:10976 | J:122148 |